These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28346588)

  • 1. Association Between Childhood-Onset Epilepsy and Amyloid Burden 5 Decades Later.
    Joutsa J; Rinne JO; Hermann B; Karrasch M; Anttinen A; Shinnar S; Sillanpää M
    JAMA Neurol; 2017 May; 74(5):583-590. PubMed ID: 28346588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
    Insel PS; Hansson O; Mattsson-Carlgren N
    JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
    Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
    JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease.
    Villeneuve S; Vogel JW; Gonneaud J; Pichet Binette A; Rosa-Neto P; Gauthier S; Bateman RJ; Fagan AM; Morris JC; Benzinger TLS; Johnson SC; Breitner JCS; Poirier J;
    JAMA Neurol; 2018 May; 75(5):608-619. PubMed ID: 29482212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.
    Jack CR; Wiste HJ; Weigand SD; Knopman DS; Vemuri P; Mielke MM; Lowe V; Senjem ML; Gunter JL; Machulda MM; Gregg BE; Pankratz VS; Rocca WA; Petersen RC
    JAMA Neurol; 2015 May; 72(5):511-9. PubMed ID: 25775353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis.
    Zeydan B; Lowe VJ; Reichard RR; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Parisi JE; Machulda MM; Vemuri P; Mielke MM; Knopman DS; Petersen RC; Jack CR; Kantarci OH; Kantarci K
    Ann Neurol; 2020 Apr; 87(4):556-567. PubMed ID: 31970802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midlife insulin resistance,
    Ekblad LL; Johansson J; Helin S; Viitanen M; Laine H; Puukka P; Jula A; Rinne JO
    Neurology; 2018 Mar; 90(13):e1150-e1157. PubMed ID: 29476033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
    Head D; Bugg JM; Goate AM; Fagan AM; Mintun MA; Benzinger T; Holtzman DM; Morris JC
    Arch Neurol; 2012 May; 69(5):636-43. PubMed ID: 22232206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual estimates of age at detectable amyloid onset for risk factor assessment.
    Bilgel M; An Y; Zhou Y; Wong DF; Prince JL; Ferrucci L; Resnick SM
    Alzheimers Dement; 2016 Apr; 12(4):373-9. PubMed ID: 26588863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults.
    Donovan NJ; Okereke OI; Vannini P; Amariglio RE; Rentz DM; Marshall GA; Johnson KA; Sperling RA
    JAMA Psychiatry; 2016 Dec; 73(12):1230-1237. PubMed ID: 27806159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study.
    Kemppainen N; Johansson J; Teuho J; Parkkola R; Joutsa J; Ngandu T; Solomon A; Stephen R; Liu Y; Hänninen T; Paajanen T; Laatikainen T; Soininen H; Jula A; Rokka J; Rissanen E; Vahlberg T; Peltoniemi J; Kivipelto M; Rinne JO
    Neurology; 2018 Jan; 90(3):e206-e213. PubMed ID: 29263220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.
    Gupta VB; Laws SM; Villemagne VL; Ames D; Bush AI; Ellis KA; Lui JK; Masters C; Rowe CC; Szoeke C; Taddei K; Martins RN;
    Neurology; 2011 Mar; 76(12):1091-8. PubMed ID: 21422459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
    Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
    JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
    Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
    JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
    Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
    Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.
    Gu Y; Razlighi QR; Zahodne LB; Janicki SC; Ichise M; Manly JJ; Devanand DP; Brickman AM; Schupf N; Mayeux R; Stern Y
    PLoS One; 2015; 10(7):e0123743. PubMed ID: 26221954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.
    Scheinin NM; Aalto S; Koikkalainen J; Lötjönen J; Karrasch M; Kemppainen N; Viitanen M; Någren K; Helin S; Scheinin M; Rinne JO
    Neurology; 2009 Oct; 73(15):1186-92. PubMed ID: 19726751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.